These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19815240)

  • 1. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
    Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
    Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
    Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in cardiovascular mortality in smokers, past-smokers and non-smokers: findings from the FRENA registry.
    Suriñach JM; Alvarez LR; Coll R; Carmona JA; Sanclemente C; Aguilar E; Monreal M;
    Eur J Intern Med; 2009 Sep; 20(5):522-6. PubMed ID: 19712858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
    Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
    Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease.
    McDermott MM; Mandapat AL; Moates A; Albay M; Chiou E; Celic L; Greenland P
    Arch Intern Med; 2003 Oct; 163(18):2157-62. PubMed ID: 14557213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
    Diehm C; Allenberg JR; Pittrow D; Mahn M; Tepohl G; Haberl RL; Darius H; Burghaus I; Trampisch HJ;
    Circulation; 2009 Nov; 120(21):2053-61. PubMed ID: 19901192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry.
    Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
    Mechtouff L; Touzé E; Steg PG; Ohman EM; Goto S; Hirsch AT; Röther J; Aichner FT; Weimar C; Bhatt DL; Alberts MJ; Mas JL;
    J Intern Med; 2010 Jun; 267(6):621-33. PubMed ID: 20210837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease.
    Nicoloff AD; Taylor LM; Sexton GJ; Schuff RA; Edwards JM; Yeager RA; Landry GJ; Moneta GL; Porter JM;
    J Vasc Surg; 2002 Jan; 35(1):38-46; discussion 46-7. PubMed ID: 11802131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
    Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.